Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUTEP LIMITED Director's Dealing 2025

Apr 7, 2025

65122_rns_2025-04-07_5d31a33f-5d30-4786-8cc0-da0023a06369.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity IMMUTEP LIMITED (ASX:IMM) ABN 90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr Frederic Triebel
Date of last notice 10 December 2024

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct or indirect interest Direct or indirect interest Direct Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.
Date of change 3 April 2025
No. of securities held prior to cha nge 8,653,7
(ASX:5,400,0(ASX:
17,061Ri
Class 1.) Fully Paid Ordinary Shares2.) Performance Rights
Number acquired 1,800,000 Fully Paid Ordinary Shares (ASX:IMM)
Number disposed 1800000PerformanceRights(ASX:
,, IMMAM)
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation Nil for the issue of 1,800,000 shares. Noamount is payable upon exercise of the 1stand 2nd tranches of Performance Rightswhich were approved by shareholders at the2021 AGM.
No. of securities held after change 10,453,764Fully paid ordinaryshares (ASX” IMM)3,600,000PerformanceRights(ASX: IMMAM)17,061American Depository Receipts(ADRs). Note that the ADR to FPORatio is 1:10
Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy-back 1,800,000 shares were issued upon vestingand exercising of 1st and 2nd tranche ofPerformance Rights out of the 2,700,000Performance Rights which were issued to DrTriebel in accordance with shareholderapproval obtained at the 2021 AGM. Oneordinary fully paid share was acquired foreach PerformanceRight that vested.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation
Interest after change
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? N/A
If so, was prior written clearance provided to allow the tradeto proceed during this period? No
If prior written clearance was provided, on what date was thisprovided? No
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3